Latest News
Biogen Inc.
- Biogen Inc. Estimates – LS:789617
- DHL Supply Chain and Biogen expand health logistics partnership in Türkiye
- Biogen-backed Estuary nabs $93M for kidney disease gene therapy
- The new Biogen: How dealmaking is redefining a nearly five-decade legacy
- Biogen is set for big gains on slate of trial data releases, JPMorgan says
- JPMorgan Upgrades Biogen on 2027 Pipeline Catalysts
- Biogen Upgraded to Buy at J.P. Morgan. How the Stock Could Rise 28%.
- Biogen announces phase 2 data for cutaneous lupus erythematosus
- Biogen’s big lupus bet gets boost from new durability data for skin disease
- Biogen's experimental lupus drug shows benefit against skin symptoms
- Biogen Pharmachem 31st AGM passes all resolutions with strong votes
- Biogen springs social media kidney health campaign with Olympic gymnast Suni Lee
Headlines from the last 30 days, linking to the original publishers. See all market news →